Since tumor cells have an increased metabolic rate, the expression of SLC2A1 is often deregulated in different cancer types [31] and since they are involved in the support of tumor cells with energy, they present therapeutic targets [31]. This evidence concerns the gene SLC2A1 and neoplasm.